Rubidium Fluoratum (Hahnemann Laboratories, Inc.)


Welcome to the PulseAid listing for the Rubidium Fluoratum drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hahnemann Laboratories, Inc.
NON-PROPRIETARY NAME: Rubidium Fluoratum
SUBSTANCE NAME: RUBIDIUM FLUORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: BUCCAL; ORAL; SUBLINGUAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00


Rubidium Fluoratum HUMAN OTC DRUG Details:

Item DescriptionRubidium Fluoratum from Hahnemann Laboratories, Inc.
LABELER NAME: Hahnemann Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/[hp_C])
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63545-673_44cfb486-a602-10ee-e054-00144ff8d46c
PRODUCT NDC: 63545-673
APPLICATION NUMBER:

Other RUBIDIUM FLUORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hahnemann Laboratories, Inc.Rubidium Fluoratum